Mostrando 6 resultados de: 6
Filtros aplicados
Publisher
American Journal of Therapeutics(6)
Association between apoliprotein E gene polymorphism and hypercholesterolemic phenotype in maracaibo, Zulia State, Venezuela
ArticleAbstract: Apoliprotein (Apo) E gene polymorphisms have been associated with high plasma lipids levels and cardPalabras claves:ApoE, Cardiovascular disease, hypercholesterolemia, Lipids profile, polymorphismsAutores:Arráiz N., Carem Prieto, Escalona C., Reyes F., Rondón N., Sánchez M.P., Sanz E., Valmore Bermúdez, Velasco M.Fuentes:scopusAn elevated level of physical activity is associated with normal lipoprotein(a) levels in individuals from Maracaibo, Venezuela
ArticleAbstract: Coronary artery disease is the main cause of death worldwide. Lipoprotein(a) [Lp(a)], is an independPalabras claves:Cardiovascular Risk, Lifestyle, lipoprotein(a), Physical activityAutores:Acosta L., Añez-Ramos R., Aparicio D., Arráiz N., Cano R.A., Cano-Ponce C., Colmenares C., Faria J., Finol F., Mengual-Moreno E., Peñaranda L., Pineda C., Rodriguez D., Rojas E.R., Rojas-Quintero J., Sanchez W., Sorell L.T., Toledo A.C., Urribarí J., Valmore Bermúdez, Velasco M.Fuentes:scopusNovel mutations identification in exon 4 of LDLR gene in patients with moderate hypercholesterolemia in a venezuelan population
ArticleAbstract: Familial hypercholesterolemia (FH) is an autosomal dominant disease characterized by increase in lowPalabras claves:Coronary artery disease, Familial hypercholesterolemia, Frameshift mutations, LDL-receptor, PCR-SSCPAutores:Arráiz N., Borjas L., Carem Prieto, Mujica E., Reyes F., Reyna-Villasmil N., Rondón N., Solís E., Valmore Bermúdez, Velasco M.Fuentes:googlescopusPPAR-γ agonists and their role in type 2 diabetes mellitus management
ReviewAbstract: Type 2 diabetes mellitus and obesity are the most frequent endocrine-metabolic diseases in the worldPalabras claves:diabetes mellitus, Insulin Resistance, PPARI, ThiazolidenedionesAutores:Arráiz N., Finol F., Parra M.G., Parra N., Peñaranda L., Pérez A., Rojas-Quintero J., Valmore Bermúdez, Velasco M., Vílchez D.Fuentes:scopusLipoprotein(a): From molecules to therapeutics
ReviewAbstract: Lipoprotein (a) [Lp(a)] was discovered by Kare Berg in 1963 from the study of low-density lipoproteiPalabras claves:Atherogenesis, Cardiovascular disease, Hyperlipoproteinemia(a), lipoprotein(a), therapeuticsAutores:Amell A., Aparicio D., Arráiz N., Cabrera M., Canelón R., Cano R.A., Cano-Ponce C., Faria J., Gotera D., Guerra-Torres X.E., Mengual-Moreno E., Reyna-Villasmil N., Rojas E.R., Sorell L.T., Valmore Bermúdez, Velasco M.Fuentes:scopusThe maracaibo city metabolic syndrome prevalence study: Design and scope
ArticleAbstract: The metabolic syndrome (MS) is a conglomerate of interrelated risk factors-including obesity, atheroPalabras claves:Blood pressure, Cardiovascular Risk Factors, cross-sectional studies, dyslipidemia, Metabolic syndromeAutores:Amell A., Arráiz N., Cabrera M., Cano J.R., Cano R.A., Cano-Ponce C., Finol F., González J., Luti Y., Marcano R.P., Mengual-Moreno E., Miranda J.L., Montes J., Reyna-Villasmil N., Rojas E.R., Sánchez D., Sanchez W., Valmore Bermúdez, Vega L., Velasco M.Fuentes:scopus